Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults
Clinical trial NCT00098098 · COMPLETED
Trial details
- NCT number
- NCT00098098
- Sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.